Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (8)

2024

  1. The cardiomyopathy of cystic fibrosis: a modern form of Keshan disease

    Frontiers in Cardiovascular Medicine, Vol. 11

2022

  1. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives

    Microorganisms, Vol. 10, Núm. 4

2020

  1. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

2015

  1. In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: Implications of the innate immune response

    Mucosal Immunology, Vol. 8, Núm. 2, pp. 362-371

  2. Response to "In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: Implications of the innate immune response"

    Mucosal Immunology

  3. Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients

    Archivos de Bronconeumologia, Vol. 51, Núm. 3, pp. 140-150

2014

  1. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study

    Journal of Cystic Fibrosis, Vol. 13, Núm. 6, pp. 716-722